NCT05959421View on ClinicalTrials.gov

Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Ebola Vaccine
Interventions
BIOLOGICAL

ERVEBO® (rVSV∆G-ZEBOV-GP)

intramuscular vaccination

BIOLOGICAL

ERVEBO® (rVSV∆G-ZEBOV-GP)

intramuscular vaccination

Trial Locations (2)

20359

Bernhard Nocht Centre for Clinical Trials (BNCCT), Hamburg

60590

University Hospital Frankfurt (KGU), Frankfurt

Sponsors

Collaborators (1)

Goethe University
All Listed Sponsors
collaborator

Bernhard Nocht Institute for Tropical Medicine

OTHER_GOV

collaborator

Goethe University

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Monipol Deutschland GmbH

UNKNOWN

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER